chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pyrexia, Ultrasound scan
Clinical narrative: chills; lymphadenopathy; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), LYMPHADENOPATHY (lymphadenopathy) and CHILLS (chills) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 05-Feb-2021, the patient experienced LYMPHADENOPATHY (lymphadenopathy). On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and AMOXICILLIN, CLAVULANIC ACID (AUGMENTINE [AMOXICILLIN;CLAVULANIC ACID]) at an unspecified dose and frequency. On 03-Feb-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, LYMPHADENOPATHY (lymphadenopathy) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Ultrasound scan: inconclusive (Inconclusive) It showed enlarged lymph nodes on  right submandibular lymphadenopathy..         Lab data: Blood work and results are normal. concomitant medication include Tylenol, ibuprofen, augmentin
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: chills really badly for 24 hrs; felt tired & fatigued.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills really badly for 24 hrs) and FATIGUE (felt tired & fatigued.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021 at 3:15 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced CHILLS (chills really badly for 24 hrs). 27-Mar-2021, the patient experienced FATIGUE (felt tired & fatigued.). At the time of the report, CHILLS (chills really badly for 24 hrs) and FATIGUE (felt tired & fatigued.) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Rash papular, Vaccination site pain
Clinical narrative: Rash Papular; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (Rash Papular) and VACCINATION SITE PAIN (vaccination site pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH PAPULAR (Rash Papular) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, RASH PAPULAR (Rash Papular) and VACCINATION SITE PAIN (vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy
Clinical narrative: Pregnancy and received 1st dose of Moderna COVID 19 vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnancy and received 1st dose of Moderna COVID 19 vaccine) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 30-Mar-2021, the patient experienced PREGNANCY (Pregnancy and received 1st dose of Moderna COVID 19 vaccine). At the time of the report, PREGNANCY (Pregnancy and received 1st dose of Moderna COVID 19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported   No treatment medication reported
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Four to five  children who are below 18 year and received the first dose of Moderna covid-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four to five children who are below 18 year and received the first dose of Moderna covid-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four to five children who are below 18 year and received the first dose of Moderna covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four to five  children who are below 18 year and received the first dose of Moderna covid-19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information reported. only 2 children got vaccine for both the doses . the children took vaccine under the age   This case was linked to MOD-2021-244154 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received on 01-Jul-2021: It was reported that 2 children received got vaccine and they got second dose also.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Left side of the body feels weird, feeling odd; Feeling lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Left side of the body feels weird, feeling odd) and DIZZINESS (Feeling lightheaded) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced FEELING ABNORMAL (Left side of the body feels weird, feeling odd) and DIZZINESS (Feeling lightheaded). At the time of the report, FEELING ABNORMAL (Left side of the body feels weird, feeling odd) and DIZZINESS (Feeling lightheaded) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: Patient couldn't receive the 2nd dose; Exposed to COVID-19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient couldn't receive the 2nd dose) and EXPOSURE TO SARS-COV-2 (Exposed to COVID-19) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in February 2021. Concurrent medical conditions included Hypertension ("Patient is under high blood pressure medication").    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient couldn't receive the 2nd dose). In February 2021, the patient experienced EXPOSURE TO SARS-COV-2 (Exposed to COVID-19). On 03-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Patient couldn't receive the 2nd dose) had resolved. At the time of the report, EXPOSURE TO SARS-COV-2 (Exposed to COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter stated that the patient could not get the scheduled 2nd dose of vaccine on 02-Feb-2021 as she was exposed to COVID-19 and later the vaccination center personnel declined to vaccinate as the recommended time period was passed.    Concomitant medications included High blood pressure medications. Treatment information was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chest discomfort, Chills, Fatigue
Clinical narrative: Congestion in chest; Back aches; Describe in one word was like Flu; Chills; Headache; Fatigue; Muscle ache/ all body ache; Hip aches; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Hypercholesteremia, Cancer and Hypertension.   On 29-Mar-2021 at 2:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle ache/ all body ache) and ARTHRALGIA (Hip aches). At the time of the report, CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle ache/ all body ache) and ARTHRALGIA (Hip aches) outcome was unknown.            Concomitant medications include cholesterol medication, high blood pressure medication and anticancer medication. treatment medication was not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Myalgia
Clinical narrative: Congestion in chest; Back aches; Describe in one word was like Flu; Chills; Headache; Fatigue; Muscle ache/ all body ache; Hip aches; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Hypercholesteremia, Cancer and Hypertension.   On 29-Mar-2021 at 2:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle ache/ all body ache) and ARTHRALGIA (Hip aches). At the time of the report, CHEST DISCOMFORT (Congestion in chest), BACK PAIN (Back aches), INFLUENZA LIKE ILLNESS (Describe in one word was like Flu), CHILLS (Chills), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle ache/ all body ache) and ARTHRALGIA (Hip aches) outcome was unknown.            Concomitant medications include cholesterol medication, high blood pressure medication and anticancer medication. treatment medication was not reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Illness, Nausea
Clinical narrative: Could not go to work - still sick; Arm at the injection site is sore; Under arm is sore; Weak / Have no strength; Sluggish; Headache; Bad chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), ILLNESS (Could not go to work - still sick) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), HEADACHE (Headache), CHILLS (Bad chills) and NAUSEA (Nausea). On 25-Mar-2021, the patient experienced ILLNESS (Could not go to work - still sick) and VACCINATION SITE PAIN (Arm at the injection site is sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Mar-2021, ILLNESS (Could not go to work - still sick) and VACCINATION SITE PAIN (Arm at the injection site is sore) had resolved. At the time of the report, PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), HEADACHE (Headache), CHILLS (Bad chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sluggishness, Vaccination site pain
Clinical narrative: Could not go to work - still sick; Arm at the injection site is sore; Under arm is sore; Weak / Have no strength; Sluggish; Headache; Bad chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), ILLNESS (Could not go to work - still sick) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), HEADACHE (Headache), CHILLS (Bad chills) and NAUSEA (Nausea). On 25-Mar-2021, the patient experienced ILLNESS (Could not go to work - still sick) and VACCINATION SITE PAIN (Arm at the injection site is sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Mar-2021, ILLNESS (Could not go to work - still sick) and VACCINATION SITE PAIN (Arm at the injection site is sore) had resolved. At the time of the report, PAIN IN EXTREMITY (Under arm is sore), ASTHENIA (Weak / Have no strength), SLUGGISHNESS (Sluggish), HEADACHE (Headache), CHILLS (Bad chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Magnetic resonance imaging head, Magnetic resonance imaging neck, Rash, SARS-CoV-1 test negative
Clinical narrative: symptoms (massive rash) got worse; symptoms (neurologly issues,numbly,muscle soreness, skin it gets inflamed and tingling in her hands) got worse; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONDITION AGGRAVATED (symptoms (neurologly issues,numbly,muscle soreness, skin it gets inflamed and tingling in her hands) got worse) and RASH (symptoms (massive rash) got worse) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced CONDITION AGGRAVATED (symptoms (neurologly issues,numbly,muscle soreness, skin it gets inflamed and tingling in her hands) got worse). On 30-Mar-2021, the patient experienced RASH (symptoms (massive rash) got worse). The patient was treated with FLUOXETINE HYDROCHLORIDE (PROZAC) at an unspecified dose and frequency; CORTISONE for Rash, at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, CONDITION AGGRAVATED (symptoms (neurologly issues,numbly,muscle soreness, skin it gets inflamed and tingling in her hands) got worse) and RASH (symptoms (massive rash) got worse) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Magnetic resonance imaging head: inconclusive (Inconclusive) inconclusive. On 03-Feb-2021, Magnetic resonance imaging neck: inconclusive (Inconclusive) inconclusive. On 03-Feb-2021, SARS-CoV-1 test negative: negative (Negative) negative.         The symptoms got worse after the second dose of vaccine. Treatment activities for event was done with muscle relaxers, steroids. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD21-065644, MOD21-065708 (E2B Linked Report).; Sender's Comments:  MOD21-065644:MOD-2021-062151 - 1st Dose of Vaccine- For Wife MOD21-065708:AE of Husband
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site urticaria, Malaise, Pruritus
Clinical narrative: itchiness; found a cluster of hives in the upper left arm at the injection site; feel under the weather; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel under the weather), PRURITUS (itchiness) and INJECTION SITE URTICARIA (found a cluster of hives in the upper left arm at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced MALAISE (feel under the weather). On 30-Mar-2021, the patient experienced PRURITUS (itchiness) and INJECTION SITE URTICARIA (found a cluster of hives in the upper left arm at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (feel under the weather), PRURITUS (itchiness) and INJECTION SITE URTICARIA (found a cluster of hives in the upper left arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Somnolence, Spinal pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping most of the day and night), SPINAL PAIN (spinal cord pain increased after vaccine) and FATIGUE (extreme exhaustion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for an unknown indication. The patient's past medical history included Spinal cord injury. Concurrent medical conditions included Spinal pain. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping most of the day and night), SPINAL PAIN (spinal cord pain increased after vaccine) and FATIGUE (extreme exhaustion). At the time of the report, SOMNOLENCE (sleeping most of the day and night), SPINAL PAIN (spinal cord pain increased after vaccine) and FATIGUE (extreme exhaustion) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient is on pain medications and muscle relaxant's for spinal pain.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Hot/ arm was hot to touch where the injection was; Arm is still red/ a big red patch where the injection was; sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot/ arm was hot to touch where the injection was), VACCINATION SITE ERYTHEMA (Arm is still red/ a big red patch where the injection was) and VACCINATION SITE PAIN (sore) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included FISH OIL from 2010 to an unknown date, MULTIVITAMIN [VITAMINS NOS] from 2000 to an unknown date, CHASTE TREE [VITEX AGNUS-CASTUS] from 2019 to an unknown date and MAGNESIUM from 2019 to an unknown date for Supplementation therapy.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot/ arm was hot to touch where the injection was), VACCINATION SITE ERYTHEMA (Arm is still red/ a big red patch where the injection was) and VACCINATION SITE PAIN (sore). At the time of the report, VACCINATION SITE WARMTH (Hot/ arm was hot to touch where the injection was), VACCINATION SITE ERYTHEMA (Arm is still red/ a big red patch where the injection was) and VACCINATION SITE PAIN (sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other Concomitant medications include herbal medicines  No treatment medications were reported. Non drug treatment includes cold ice packs every half hour to cool it down   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03 Jun 2021. Patient demographics were added, Concomitant medications were added, Event(vaccination site pain) was added and outcome of events changed from not recovered to recovered
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Pain, Swelling, Vaccination site erythema, Vaccination site pain
Clinical narrative: soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness and swelling; soreness and swelling; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness and swelling), SWELLING (soreness and swelling), VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE and ANTACID for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN (soreness and swelling) and SWELLING (soreness and swelling). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site). On 24-Mar-2021, PAIN (soreness and swelling) and SWELLING (soreness and swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Angiogram: inconclusive (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness and swelling; soreness and swelling; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness and swelling), SWELLING (soreness and swelling), VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE and ANTACID for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN (soreness and swelling) and SWELLING (soreness and swelling). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site). On 24-Mar-2021, PAIN (soreness and swelling) and SWELLING (soreness and swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Angiogram: inconclusive (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: Loss of appetite; Severe headache; Nausea; vomiting; Chills; Fatigue; Pain at the site of the injection Left arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LISINOPRIL, OMEPRAZOLE and MELOXICAM for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 24-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the site of the injection Left arm). On 30-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at the site of the injection Left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Loss of appetite; Severe headache; Nausea; vomiting; Chills; Fatigue; Pain at the site of the injection Left arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LISINOPRIL, OMEPRAZOLE and MELOXICAM for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 24-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the site of the injection Left arm). On 30-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Loss of appetite), HEADACHE (Severe headache), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at the site of the injection Left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot
Clinical narrative: Felt very hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt very hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L209) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FEELING HOT (Felt very hot). At the time of the report, FEELING HOT (Felt very hot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient did not take any treatment medication for the event.   This case was linked to MOD-2021-065798 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received and contains no new information
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: Swelling of arm; Lump at injection site; Hot to the touch at injection site; Sore arm; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling of arm), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE WARMTH (Hot to the touch at injection site), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling of arm), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE WARMTH (Hot to the touch at injection site), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, PERIPHERAL SWELLING (Swelling of arm), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE WARMTH (Hot to the touch at injection site), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by the reporter  No treatment medication reported by the reporter
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), PYREXIA (fever) and MYALGIA (very bad muscle aches and spasms in her back.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN (soreness), PYREXIA (fever) and MYALGIA (very bad muscle aches and spasms in her back.). On 30-Mar-2021, PYREXIA (fever) had resolved. At the time of the report, PAIN (soreness) and MYALGIA (very bad muscle aches and spasms in her back.) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: administered 1ml to five patients; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (administered 1ml to five patients) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (administered 1ml to five patients). On 30-Mar-2021, ACCIDENTAL OVERDOSE (administered 1ml to five patients) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD21-065824; MOD21-065792; MOD21-065826; MOD21-065852, MOD-2021-062195, MOD-2021-062261 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus
Clinical narrative: Her arm became itchy; Her upper arm became warm between her shoulder and half of her arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Her upper arm became warm between her shoulder and half of her arm) and PRURITUS (Her arm became itchy) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included WARFARIN, CLONIDINE, CALCITRIOL, FUROSEMIDE, SIMVASTATIN, VALSARTAN and INSULIN GLARGINE (TOUJEO) for an unknown indication.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced FEELING HOT (Her upper arm became warm between her shoulder and half of her arm). On 29-Mar-2021, the patient experienced PRURITUS (Her arm became itchy). At the time of the report, FEELING HOT (Her upper arm became warm between her shoulder and half of her arm) had resolved and PRURITUS (Her arm became itchy) outcome was unknown.            Patient stated that she applied cold compress on her arm. No treatment medication were provided. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: Patient demographics updated, concomitant medications added, events updated. On 15-Jun-2021: Event details added.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching; swelling; little bit of soreness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (little bit of soreness at the injection site), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swelling) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included Pain (soreness at injection site) on 09-Mar-2021, Itching on 09-Mar-2021 and Swelling (swelling at injection site). Concomitant products included BUPROPION, FLUOXETINE, LORAZEPAM and OMEPRAZOLE for an unknown indication.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 21-Mar-2021, the patient experienced VACCINATION SITE PAIN (little bit of soreness at the injection site). On 29-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swelling). On 22-Mar-2021, VACCINATION SITE PAIN (little bit of soreness at the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Treatment information provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Pain around the injection site; swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included CHLORTHALIDONE, AMLODIPINE, ATORVASTATIN, GABAPENTIN and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site). On 13-Mar-2021, INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included alfaquin eye drops for an unknown indication.    Treatment of the events included, paracetamol and cold compress.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Eye swelling, Fatigue, Feeling cold, Pain in extremity
Clinical narrative: face is swollen; eyes are swollen, looks like someone punched her; felt cold; lower back hurts; sore arm; really tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Past medical history not provided).   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired). At the time of the report, SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired) outcome was unknown.            Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: face is swollen; eyes are swollen, looks like someone punched her; felt cold; lower back hurts; sore arm; really tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Past medical history not provided).   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired). At the time of the report, SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired) outcome was unknown.            Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: Loss of appetite; Chills; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, DECREASED APPETITE (Loss of appetite), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported. Treatment details included Ibuprofen.